Stay updated with breaking news from Calcimedica. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Meritage Portfolio Management lifted its holdings in shares of CalciMedica, Inc. (NASDAQ:CALC – Free Report) by 360.0% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 46,000 shares of the company’s stock after purchasing an additional 36,000 shares during the period. Meritage Portfolio Management owned 0.81% of CalciMedica […]
/PRNewswire/ -- CalciMedica Inc. (CalciMedica or the Company) (Nasdaq: CALC), a clinical-stage biopharmaceutical company focused on developing novel calcium...
HC Wainwright restated their buy rating on shares of CalciMedica (NASDAQ:CALC – Free Report) in a research note issued to investors on Tuesday, Benzinga reports. The brokerage currently has a $20.00 price target on the stock. Separately, Oppenheimer reissued an outperform rating and set a $14.00 price objective on shares of CalciMedica in a report […]
Treatment with Auxora™ shown to potentially reduce the severity of asparaginase-associated pancreatitis, also called asparaginase-induced pancreatic toxicity,...
CalciMedica, Inc. (NASDAQ:CALC – Get Rating)’s share price rose 0.3% on Monday . The company traded as high as $5.55 and last traded at $5.29. Approximately 14,644 shares traded hands during mid-day trading, an increase of 76% from the average daily volume of 8,312 shares. The stock had previously closed at $5.28. Wall Street Analyst […]
Results support the initiation of clinical studies to assess Orai1 inhibition in patients with recurrent acute pancreatitis and early CP Data show that inhibiting Orai1-mediated store-operated Ca2+... | June 6, 2023
CalciMedica (NASDAQ:CALC – Get Rating) is one of 995 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its rivals? We will compare CalciMedica to related businesses based on the strength of its profitability, risk, valuation, analyst recommendations, earnings, institutional ownership and dividends. Profitability This table compares CalciMedica and […]
Raven Jaeger, M.S. named Chief Regulatory Officer and Andrew Cunningham, M.D., MRCPI, named Senior Vice President, Clinical DevelopmentLA JOLLA, Calif., May 23, 2023 -- CalciMedica Inc. , a... | May 23, 2023